Radiotherapy and radiation oncology play a key role in the clinical management of patients
suffering from oncological diseases. In clinical routine, anatomic imaging such as contrast …

Background Prostate-specific membrane antigen (PSMA) PET is highly sensitive in
identifying disease recurrence in men with biochemical recurrence of prostate cancer (BCR) …

The progressive integration of positron emission tomography/computed tomography
(PET/CT) imaging in radiation therapy has its rationale in the biological intertumoral and …

Since the development of fibroblast activation protein–targeted radiopharmaceuticals, 68Ga-
fibroblast activation protein inhibitor (FAPI) PET/CT has been found to be suitable for …

Importance Prostate-specific antigen membrane positron-emission tomography (PSMA-PET)
is increasingly used to guide salvage radiotherapy (sRT) after radical prostatectomy for …

Prostate cancer (PCa) faces great challenges in early diagnosis, which often leads not only
to unnecessary, invasive procedures, but to over-diagnosis and treatment as well, thus …

Purpose To develop a CT-based radiomic signature to predict biochemical recurrence
(BCR) in prostate cancer patients after sRT guided by positron-emission tomography …

Purpose This study aims to evaluate the association of the maximum standardized uptake
value (SUVmax) in positron-emission tomography targeting prostate-specific membrane …

Purpose: Prostate specific antigen persistence after radical prostatectomy is associated with
adverse outcomes in patients with prostate cancer. We sought to define regions at risk for …

Purpose Prostate-specific membrane antigen positron emission tomography (PSMA-PET) is
increasingly used to guide salvage radiation therapy (sRT) in patients with prostate cancer …